221 related articles for article (PubMed ID: 11126166)
21. A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cervical cytology.
Mayeaux EJ; Harper MB; Abreo F; Pope JB; Phillips GS
J Fam Pract; 1995 Jan; 40(1):57-62. PubMed ID: 7807039
[TBL] [Abstract][Full Text] [Related]
22. Should all women with cervical atypia be referred for colposcopy: a HARNET study. Harrisburgh Area Research Network.
Slawson DC; Bennett JH; Simon LJ; Herman JM
J Fam Pract; 1994 Apr; 38(4):387-92. PubMed ID: 8163964
[TBL] [Abstract][Full Text] [Related]
23. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
Int J STD AIDS; 2008 Jun; 19(6):385-92. PubMed ID: 18595876
[TBL] [Abstract][Full Text] [Related]
24. A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities.
Andersson S; Dillner L; Elfgren K; Mints M; Persson M; Rylander E
Acta Obstet Gynecol Scand; 2005 Oct; 84(10):996-1000. PubMed ID: 16167918
[TBL] [Abstract][Full Text] [Related]
25. A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study.
Pan Q; Belinson JL; Li L; Pretorius RG; Qiao YL; Zhang WH; Zhang X; Wu LY; Rong SD; Sun YT
Acta Cytol; 2003; 47(1):45-50. PubMed ID: 12585030
[TBL] [Abstract][Full Text] [Related]
26. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
27. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
[TBL] [Abstract][Full Text] [Related]
28. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
Dhaubhadel P; Vaidya A; Choudhary P
JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears.
Derchain SF; Rabelo-Santos SH; Sarian LO; Zeferino LC; de Oliveira Zambeli ER; do Amaral Westin MC; de Angelo Andrade LA; Syrjänen KJ
Gynecol Oncol; 2004 Dec; 95(3):618-23. PubMed ID: 15581973
[TBL] [Abstract][Full Text] [Related]
30. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL.
Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Woodward L
J Fam Pract; 1998 Feb; 46(2):136-41. PubMed ID: 9487319
[TBL] [Abstract][Full Text] [Related]
31. Expanded cytological referral criteria for colposcopy in cervical screening: comparison with human papillomavirus testing.
Paraskevaidis E; Malamou-Mitsi V; Koliopoulos G; Pappa L; Lolis E; Georgiou I; Agnantis NJ
Gynecol Oncol; 2001 Aug; 82(2):355-9. PubMed ID: 11531293
[TBL] [Abstract][Full Text] [Related]
32. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
33. [Colposcopy and cervical biopsy in patients with routine Papanicolaou smear].
Milla Villeda RH; Alvarado Zaldívar G; Sánchez Anguiano LF; Barrera Tovar M; Vázquez Arreola I
Ginecol Obstet Mex; 1997 Jun; 65():235-8. PubMed ID: 9273333
[TBL] [Abstract][Full Text] [Related]
34. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
[TBL] [Abstract][Full Text] [Related]
35. Comparison of immediate and deferred colposcopy in a cervical screening program.
Parham GP; Andrews NR; Lee ML
Obstet Gynecol; 2000 Mar; 95(3):340-4. PubMed ID: 10711540
[TBL] [Abstract][Full Text] [Related]
36. Speculoscopy for Triage of Patients with an Abnormal Pap Smear: Data from the GISPE Study.
Costa S; De Nuzzo M; Terzano P; Syrjänen K; Abbiati R; Grossi E; Quagliarella G; Bovicelli A; Zamparelli A; Bovicelli L
J Low Genit Tract Dis; 2000 Oct; 4(4):212-6. PubMed ID: 25951158
[TBL] [Abstract][Full Text] [Related]
37. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
Budge M; Halford J; Haran M; Mein J; Wright G
Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
[TBL] [Abstract][Full Text] [Related]
38. CIN 2/3 and cervical cancer after an ASCUS pap smear. A 7-year, prospective study of the Norwegian population-based, coordinated screening program.
Nygård JF; Sauer T; Skjeldestad FE; Skare GB; Thoresen SØ
Acta Cytol; 2003; 47(6):991-1000. PubMed ID: 14674068
[TBL] [Abstract][Full Text] [Related]
39. A second Pap smear during colposcopy: is it really worth it?
Kourounis GS; Michail GD; Ravazoula P
Eur J Gynaecol Oncol; 2004; 25(4):475-7. PubMed ID: 15285307
[TBL] [Abstract][Full Text] [Related]
40. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]